By David Atkinson David Atkinson is a Postdoctoral Fellow at Georgetown University Law Center and a 2026-2027 IPPI Edison Fellow. The legal argument that could either protect copyright forever — […]
Most-Favored-Nation (MFN) Drug Pricing: You Can’t Import European Prices Without Importing European Tradeoffs
By Dr. Gabriela Lenarczyk Dr. Lenarczyk is a 2024-2025 Edison Fellow. This blog post is in partial fulfillment of obligations for the Thomas Edison Innovation Law and Policy Fellowship. Recently resurfaced […]
IPPI 2026 Spring Progress Report
IPPI 2026 Spring Progress Report (December 2025- February 2026) Navigation IPPI Hosted and Co-Hosted Events News & Speaking Engagements Scholarship & Other Writing Greetings from IPPI Research Professor & Executive […]
IPPI 2025 Winter Progress Report
IPPI 2025 Winter Progress Report (September – November 2025) Navigation IPPI Hosted and Co-Hosted Events News & Speaking Engagements Scholarship & Other Writing Greetings from IPPI Research Professor & Executive […]
The Problem With the ‘Patent Thicket’ Narrative
By Kristen Osenga Cross-posted with permission from Professor Osenga’s December 8, 2025, LinkedIn article I’ve seen a lot of misinformation circulating online lately about patents and their role in drug […]
IPPI 2025 Fall Progress Report
IPPI Fall 2025 Progress Report (June – August 2025) Navigation IPPI Hosted and Co-Hosted Events News & Speaking Engagements Scholarship & Other Writing Greetings from IPPI Research Professor & Executive […]
TPLFA: Protecting Predatory Infringers
By Michael Doane The CEO of a small technology-based company with many groundbreaking patents in its field once asked me what the point was of obtaining patents when the company […]
IPPI Summer 2025 Progress Report
IPPI Spring 2025 Progress Report (March – May 2025) Navigation IPPI Hosted and Co-Hosted Events News & Speaking Engagements Scholarship & Other Writing Greetings from IPPI Research Professor & Executive […]
IPPI Cautions that Pharmaceutical Tariffs Would Harm Patients and U.S. Innovation Leadership
IPPI has submitted formal comments to the U.S. Department of Commerce regarding its Section 232 investigation of pharmaceutical imports, cautioning against imposing tariffs on medicines and their ingredients. In our […]
RESTORE, PERA and PREVAIL: Bills that fix problems with the patent system
By Kristen Jakobsen Osenga As the 118th Congress drew to a close at the end of 2024, there was a spate of intellectual property activity on Capitol Hill. I was […]